BG104243A - Method for the synthesis of quinoline derivatives - Google Patents

Method for the synthesis of quinoline derivatives

Info

Publication number
BG104243A
BG104243A BG104243A BG10424300A BG104243A BG 104243 A BG104243 A BG 104243A BG 104243 A BG104243 A BG 104243A BG 10424300 A BG10424300 A BG 10424300A BG 104243 A BG104243 A BG 104243A
Authority
BG
Bulgaria
Prior art keywords
synthesis
quinoline derivatives
phenylquinoline
ethylbenzyl
alpha
Prior art date
Application number
BG104243A
Other languages
Bulgarian (bg)
English (en)
Inventor
Joseph Sisko
Mark Mellinger
Conrad Kowalski
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of BG104243A publication Critical patent/BG104243A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/50—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4
    • C07D215/52—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
BG104243A 1997-09-17 2000-03-15 Method for the synthesis of quinoline derivatives BG104243A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5930397P 1997-09-17 1997-09-17
PCT/US1998/019434 WO1999014196A1 (fr) 1997-09-17 1998-09-17 Procede de synthese de derives de quinoleine

Publications (1)

Publication Number Publication Date
BG104243A true BG104243A (en) 2001-05-31

Family

ID=22022126

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104243A BG104243A (en) 1997-09-17 2000-03-15 Method for the synthesis of quinoline derivatives

Country Status (32)

Country Link
US (6) US6335448B1 (fr)
EP (1) EP1017676B1 (fr)
JP (1) JP2001516744A (fr)
KR (1) KR20010024031A (fr)
CN (1) CN1125815C (fr)
AP (1) AP1201A (fr)
AR (1) AR015445A1 (fr)
AT (1) ATE353879T1 (fr)
AU (1) AU744538B2 (fr)
BG (1) BG104243A (fr)
BR (1) BR9812085A (fr)
CA (1) CA2303026A1 (fr)
DE (1) DE69837100T2 (fr)
DZ (1) DZ2607A1 (fr)
EA (1) EA002633B1 (fr)
ES (1) ES2283072T3 (fr)
HU (1) HUP0004855A3 (fr)
ID (1) ID24140A (fr)
IL (1) IL134991A0 (fr)
MA (1) MA24644A1 (fr)
MY (1) MY120237A (fr)
NO (1) NO314303B1 (fr)
NZ (1) NZ503307A (fr)
OA (1) OA11340A (fr)
PE (1) PE129299A1 (fr)
PL (1) PL339340A1 (fr)
SK (1) SK3672000A3 (fr)
TR (1) TR200000720T2 (fr)
TW (1) TW509678B (fr)
UY (2) UY25174A1 (fr)
WO (1) WO1999014196A1 (fr)
ZA (1) ZA988455B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.
ATE247652T1 (de) 1999-03-29 2003-09-15 Neurogen Corp 4-substituierte chinolinderivate als nk-3 und/oder gaba(a) rezeptor liganden
KR100799802B1 (ko) 2004-02-04 2008-01-31 화이자 프로덕츠 인크. 치환된 퀴놀린 화합물
CA2611060A1 (fr) * 2005-06-03 2006-12-07 R. Thomas Simpson Derives de quinoline utilises comme antagonistes de nk3
US20080194623A1 (en) * 2005-08-02 2008-08-14 Labaw Clifford S Method for the Synthesis of Quinoline Derivatives
US20080280949A1 (en) * 2005-08-11 2008-11-13 Astrazeneca Ab Oxopyridyl Quinoline Amides as Nk3 Receptor Modulators
AR057130A1 (es) * 2005-09-21 2007-11-14 Astrazeneca Ab Quinolinas de alquilsulfoxido y una composicion farmaceutica
JP2009508944A (ja) * 2005-09-21 2009-03-05 アストラゼネカ・アクチエボラーグ Nk−3受容体リガンドとしてのn−オキソ複素環及びn−オキソ−アルキルキノリン−4−カルボキシアミド類
US20090054445A1 (en) * 2006-01-27 2009-02-26 Astrazeneca Ab Amide Substituted Quinolines
CN102702099A (zh) * 2012-06-21 2012-10-03 江苏恩华药业股份有限公司 (s)-3-羟基-2-苯基-n-(1-苯基丙基)喹啉-4-甲酰胺的制备方法
CN102924375B (zh) * 2012-06-21 2015-02-18 江苏恩华药业股份有限公司 Talnetant中间体及其制备方法和应用
CN103214416A (zh) * 2013-04-26 2013-07-24 扬州大学 一种合成多取代喹啉类化合物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2776290A (en) * 1957-01-01 Hydroxy cevchoninates and carboxylic
DE69531458T2 (de) * 1994-05-27 2004-08-05 Glaxosmithkline S.P.A. Chinolinderivate als tachykinin nk3 rezeptor antagonisten
US5627193A (en) * 1995-02-09 1997-05-06 Mitsui Toatsu Chemicals, Inc. Quinoline-4-carbonylguanidine derivatives, process for producing the same and pharmaceutical preparations containing the compounds
AP1201A (en) * 1997-09-17 2003-09-01 Smithkline Beecham Corp Method for the synthesis of quinoline derivatives.

Also Published As

Publication number Publication date
EP1017676B1 (fr) 2007-02-14
MY120237A (en) 2005-09-30
UY25174A1 (es) 2001-07-31
NO20001387L (no) 2000-03-16
EP1017676A4 (fr) 2002-12-04
AP2000001767A0 (en) 2000-03-31
ATE353879T1 (de) 2007-03-15
HUP0004855A2 (hu) 2001-06-28
EA200000322A1 (ru) 2000-10-30
US20020173657A1 (en) 2002-11-21
AR015445A1 (es) 2001-05-02
UY25407A1 (es) 1999-11-17
TW509678B (en) 2002-11-11
SK3672000A3 (en) 2000-09-12
ES2283072T3 (es) 2007-10-16
IL134991A0 (en) 2001-05-20
CN1125815C (zh) 2003-10-29
MA24644A1 (fr) 1999-04-01
KR20010024031A (ko) 2001-03-26
US20020038029A1 (en) 2002-03-28
PL339340A1 (en) 2000-12-18
PE129299A1 (es) 2000-02-19
CA2303026A1 (fr) 1999-03-25
NZ503307A (en) 2002-04-26
HUP0004855A3 (en) 2001-08-28
US20060189809A1 (en) 2006-08-24
ID24140A (id) 2000-07-06
DZ2607A1 (fr) 2003-03-01
US20050171152A1 (en) 2005-08-04
AU744538B2 (en) 2002-02-28
ZA988455B (en) 1999-02-17
CN1278796A (zh) 2001-01-03
US6335448B1 (en) 2002-01-01
NO20001387D0 (no) 2000-03-16
EA002633B1 (ru) 2002-08-29
WO1999014196A1 (fr) 1999-03-25
AP1201A (en) 2003-09-01
TR200000720T2 (tr) 2000-08-21
AU9395898A (en) 1999-04-05
US20040049031A1 (en) 2004-03-11
BR9812085A (pt) 2000-09-26
OA11340A (en) 2003-12-09
DE69837100D1 (de) 2007-03-29
JP2001516744A (ja) 2001-10-02
EP1017676A1 (fr) 2000-07-12
NO314303B1 (no) 2003-03-03
DE69837100T2 (de) 2007-11-22

Similar Documents

Publication Publication Date Title
NO306294B1 (no) FremgangsmÕte for fremstilling av azetidinoner
WO2000055126A3 (fr) Nouveaux composes et compositions utiles comme inhibiteurs de protease
IL142768A0 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
HU9601857D0 (en) New benzyl-piperidine- or -tetrahydro-pyridine derivatives and processes for producing them
HU9602229D0 (en) Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace
PL325322A1 (en) Novel substituted amine compounds, method of obtaining them and therapeutic agent
SI1274685T1 (sl) Derivat piridin-1-oksida in postopek njegove transformacije v farmacevtsko ucinkovite sestavine
MY120237A (en) Method for the synthesis of quinoline derivatives
PL327171A1 (en) Novel derivatives of phenyl amine, method of obtaining them and their application as therapeutic agents
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
BG105766A (en) New process for preparing pesticidal intermediates
RU94046144A (ru) Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция
CA2214072A1 (fr) Benzo [b] thiophenes, intermediaires, procedes, compositions et methodes
EG24052A (en) Novel processes for the preparation of (r)-a (2,3-demethoxyphenyl-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethapnol
MXPA03006057A (es) Proceso para preparar (+) trans-4-p-fluorofenil -3 hidroximetil.
TR199900480T2 (xx) Kristalin farmas�tik �r�n.
IL158356A0 (en) Benzoheterocycles
MXPA03009723A (es) Procedimientos e intermediarios para preparar epoxidos substituidos de bencilo.
PL343629A1 (en) Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
WO2001083423A3 (fr) Acide 2,6-diamino-6-methyl-heptanoique et derives, procede de preparation et utilisation correspondants
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
EE200000369A (et) Isopropüülmetüül[2-(3-n-propoksüfenoksü)etüül]amiini valmistamise protsess
WO2003045909A3 (fr) Procedes et produits intermediaires pour la synthese d'azepines